Is Inogen, Inc. (INGN) a Buy, Sell, or Hold?
NASDAQ : INGN
Inogen, Inc. — News
$6.02 USD
-$0.03 (-0.5%)
- Volume
- 272.05K
- Average Volume
- 304.79K
- Market Capitalization
- $162.99M
- P/E Ratio
- -6.69
- Dividend Yield
- 0.00%
- Price Target
- $26.00
- Year High
- $9.13
- Year Low
- $5.34
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $2.74
| Source | Headline |
|---|---|
|
Inogen Q2 Earnings Beat Estimates, Sales Rise Y/Y, 2026 View Cut
INGN's Q2 revenues rise 3% as international sales climb 14.8%, but U.S. weakness led it to cut its 2026 revenue outlook. zacks.com - 2026-08-10 13:56:03 |
|
Inogen, Inc. (INGN) Q2 2026 Earnings Call Transcript
Inogen, Inc. (INGN) Q2 2026 Earnings Call Transcript seekingalpha.com - 2026-08-07 10:24:24 |
|
Inogen Q2 Earnings Call Highlights
Inogen NASDAQ: INGN reported second-quarter 2026 revenue of $95.1 million, up 3% from a year earlier, as international growth, portable oxygen concentrator demand and contributions from newer products offset continued pressure in its U.S. direct-to-consumer business. marketbeat.com - 2026-08-06 23:04:36 |
|
Inogen (INGN) Reports Q2 Loss, Tops Revenue Estimates
Inogen (INGN) came out with a quarterly loss of $0.14 per share versus the Zacks Consensus Estimate of a loss of $0.17. This compares to a loss of $0.15 per share a year ago. zacks.com - 2026-08-06 20:13:24 |
|
Inogen Announces Second Quarter 2026 Financial Results
BEVERLY, Mass.--(BUSINESS WIRE)---- $INGN #AirwayClearance--Reported second quarter revenue of $95.1 million. Company raises full-year adjusted EBITDA guidance to approximately $4.0 million. businesswire.com - 2026-08-06 16:05:00 |
|
Inogen to Report Second Quarter 2026 Financial Results on August 6, 2026
BEVERLY, Mass.--(BUSINESS WIRE)---- $INGN #AirwayClearance--Inogen to Report Second Quarter 2026 Financial Results on August 6, 2026. businesswire.com - 2026-07-16 08:30:00 |
|
Inogen Announces the Appointment of Andy Reding as Chief Operating Officer
BEVERLY, Mass.--(BUSINESS WIRE)---- $INGN #AirwayClearance--Inogen Announces the Appointment of Andy Reding as Chief Operating Officer. businesswire.com - 2026-07-01 16:05:00 |
|
Here's Why You Should Retain Inogen Stock in Your Portfolio for Now
INGN's POC strength, expanding respiratory portfolio and international momentum support growth, though U.S. revenue pressure remains a key risk. zacks.com - 2026-06-25 11:16:05 |
|
Here's Why You Should Retain Inogen Stock in Your Portfolio for Now
INGN broadens beyond portable oxygen concentrators into home respiratory care, but U.S. revenues face pressure from channel shifts. zacks.com - 2026-05-22 11:05:27 |
